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1, Introduction 
Collagens are structural glycoproteins of connective 
tissue that are secreted by various cells in a precursor 
form [ 11. The amino-terminal extension peptides of 
type I and type III procollagens have been isolated 
from de~atosp~ctic or fetal skin and have been 
used in structural studies [Z--4]. These peptides are 
biologically active in regulating procollagen bio- 
synthesis in normal and diseased fibroblasts [S&l. 
They also contain strong antigenic determinants [7]. 
The carboxy-terminal extension of procollagen type I 
has been chemically characterized using an organ 
culture system [8]. So far the carboxy-terminal 
propeptide of type III procollagen has not been 
isolated and hence subjected to structural studies. 
Continuous cell lines from human tumors provide 
a means to isolate great amounts of material normally 
secreted by the respective untr~sfo~ed cells in vivo; 
such products include ~muno~obu~s [9] and 
interferon [lo]. Although the level of procollagen- 
specific mRNA [ 11 ,121 as well as the net production 
of procollagen [13,14] are often decreased in trans- 
formation, this is not invariably the case [15]. We 
here report production of large amounts of type III 
procollagen by a continuous embryonal human 
rhabdomyosarcoma cell line. Unlike normal human 
skin fibroblasts or smooth muscle cells [16,17], these 
tumor cells produce also some basement membrane 
collagen but no type I procollagen. I~uno~stolo~c~ 
studies are consistent withthis and show only type III 
procollagen and type IV collagen in the endomysium 
around the individual skeletal muscle fibers. 
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2. Experimental 
Rhabdomyosarcoma cells (strain ATCC-CCL 136, 
American Type Culture Collection) and normal skin 
fibroblasts [ 181 were grown to confluency in minimal 
essential medium modified according to Dulbecco 
and supplemented with 10% fetal calf serum, ascorbic 
acid (50 &ml), streptomyc~ (50 &ml) and penicillin 
(400 U/ml). Cells were labeled for 24 h by adding 
[ r4C]glycine (5 /.&i/ml) or [ 3H]proline (10 pCi/ml) in 
fresh medium containing now @minopropionitrlle 
(50 pg/ml) but lacking serum and streptomycin. 
Radioactivity incorporated into proteins was measured 
in a fl scintillation counter prior to or after separating 
hydroxyproline and proline in acid-hydrolyzed 
samples on a Multichrome amino acid analyzer. 
Characterization f medium proteins by precipita- 
tion with ~monium sulphate (176 mg/ml) or NaCl 
(2.7 or 4 M), pepsin treatment and ~romato~aphy 
on DEAE cellulose, CM cellulose and agarose followed 
described procedures [ 5 ,191. Slab gel electrophoresis 
in sodium dodecylsulfate was performed according to 
Laemmli [20] using fluorography [21] for the 
visualization of protein bands. Medium was digested 
with bacterial collagenase (form III, Advanced Bio- 
facturers Corp., Lynbrook, NY) at 37’C for 60 min 
using 30 units/ml. Immunoprecipitation was 
performed with purified antibodies (lo-20 @g/ml) 
and an excess of second antibody against immuno- 
globulin. ~dio~uno~ys for type III procollagen 
and fibronectin followed pubh~ed procedures [7]. 
Indirect immunofluorescence analysis of cell layers 
and of tissues was carried out as in [18,22], 
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3. Results and discussion 
In a previous ~muno~uorescence analysis [ 181 
we have found that rhabdomyo~coma cells contain 
large amounts of intracellular type III procollagen but 
no or only little type I procollagen. The biosynthetic 
capacity of confluent cell cultures was now more 
thoroughly examined by metabolic labeling (table 1). 
About 30% of the newly synthesized proteins and 
usually > 80% of the collageneous proteins (as based 
on radioactive hydroxyproline) were secreted into the 
medium. The medium proteins include type III 
procollagen and ~bronect~ as judged from radio- 
~rn~o~~ys. Only small amounts of these two 
proteins could be detected in the cell layer. A com- 
parison with normal skin fibroblasts cultured under 
the same conditions howed that rhabdomyosarcoma 
cells produced about 2-4-times as much type III 
procollagen but 2-5fold less fibronectin. 
Analysis of the medium proteins on DEAE-cellulose 
showed a complex pattern. However, two peaks 
which accounted together for -60% of the radio- 
activity contained mainly type III ptocollagen and 
fibronectin, respectively, as judged from radio- 
~~0~~s (fig. 1A). Type I procollagen emerges 
from the DEAE-ce~~o~ column in front of the 
type III procollagen peak [ 165 but only little material 
was found in this position (fig.lA). 
The nature of the collageneous proteins was 
further examined after treating the medium with 
pepsin in order to remove most of the non-collageneous 
protein and to convert procollagen i to collagen. 
About 90% of the pepsin-resistant radioactivity was 
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Fig.1. Chromatographic separation of rhabdomyosarcoma 
cell medium proteins on DEAEcelhslose (A) and characteriza- 
tion of the pepsin-resistent collageneous protein on agarose 
ASm (B). The DEAE-cellulose column (1.8 X 8 cm) was 
equilibrated in 0.05 M Tris-HCl @H 7.4), 2 M urea and 
eluted with a linear gradient from O-O.3 M NaCl(300/ 
300 ml). The arrow denotes the start of the gradient. Total 
recovery from the column was 6%. The fractions containhtg 
type III procolla8en and fibronectin were identified by radio- 
immunoassay. The agarose column (1.5 X 120 cm) was 
equilibrated in 1 M CaCl,, 0.05 M Tris-HCl and samples run 
prior to (-ME, o- o) and after (+ME, x-x) reduction 
with 0.4% 2.mercaptoethanol. +y and QL denote the elution 
positions of y components and o chains determined in a 
calibration run with denatured type I collagen. 
insoluble in 2.7 M NaCl. This material eluted from 
agarose mainly in the position of 7 components 
(290 000 mol. wt), but a shift to the position of cy 
chains (95 000 mol. wt) was noted after reduction 
(fig.lB). Since prior to reduction only little radio- 
activity was detected in the position of cx chains the 
data indicate that rhabdomyosarcoma cells produce 
Table 1 
Analysis of protein synthesis of r~bdomyo~coma &Is by metabolic 
labeling and ~munochemi~ assaysa 
Proteht-bound radioact. (cpm/cell) Radioimmunoassay (pg/cell) 
HYPb pro Type III Fibro- 
procolla8en nectin 
Medium 0.34 0.78 6.2 1.9 
Cell layer 0.05 2.42 0.4 0.2 
a Average values from 3 experiments 
b Based en the hy~ox~ro~~pro~e ratio f SI -1% of the newly synthesized 
proteins are collagens 
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> IO-times more type III than type I procollagen. 
This observation was confirmed by CM cellulose 
chromatography showing a major peak in the 
al(III)/cx2 chain region while only little radiocativity 
was eluted in the position of al(I) chains. 
Sodium dodecyl sulfate gel electrophoresis and 
specific immunological techniques were used to verify 
the chromatographic data and to screen for additional 
proteins. An ammonium sulfate precipitate of the 
medium containing 85% of the total radioactivity 
showed 5 major electrophoretic bands (fig.2, lane 1). 
A doublet of strongly labeled bands was sensitive 
towards bacterial collagenase (fig.2, lane 2, see also 
scans a,b) and could be precipitated by antibodies 
against the amino-terminal peptide of type III 
procollagen (flg.2, lane 3). The major, slower moving 
band of the doublet comigrates with intact procollagen 
chain (150 000 mol. wt) while the faster migrating 
band may resemble a truncated form of the molecule 
[ 23,241. Collagenase digested also a doublet of slower 
migrating bands, at the 170 000 and 180 000 mol. wt 
positions (flg.2, lanes 1,2) that were precipitated with 
antibodies to human type IV collagen (fIg.2, lane 5). 
Electrophoretic analysis of pepsin-treated medium 
(2.7 M NaCl, precipitate) showed a band (fig.2, lane 4) 
which moved in the position of a! chains. In unreduced 
conditions this major band migrated in the 7 position 
(not shown). Small amounts of type AB2 collagen 
were also found in the pepsin-treated medium and 
could be precipitated between 2.7 M and 4 M NaCl. 
These polypeptides were identified by the characteris- 
tic mobility in slab gel electrophoresis when compared 
with authentic A and B chains [25]. Together the 
data demonstrate hat type III but not type I 
procollagen is the major collageneous product 
synthesized by the cells and the basement membrane 
collagens (types AB2 and IV) are minor components 
only. 
As shown above fibronectm represents a major 
non-collageneous protein secreted into the medium 
which was confirmed by’immunoprecipitation (fig.2, 
lane 6). A considerable fraction of the labeled non- 
collageneous proteins, however, are recovered in the 
cell layer (table 1) and were not identified in the 
present study. All of the above matrix glycoproteins, 
type III procollagen, fibronectin and type IV collagen, 
were detected by indirect immunofluorescence 
intracellularly but were not deposited in pericellular 
--w - 
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Fig.2. Polyacrylamide gel electrophoresis and fhrorography of 
labeled polypeptides secreted by rhabdomyosarcoma cells. 
Lane 1, ammonium sulfate precipitation of culture medium; 
lane 2, collagenase digestion followed by ammonium sulfate 
precipitation; lane 3, hnmunoprecipitation with type III 
procollagen antibodies; lane 4, pepsin digestion of culture 
medium followed by 2.7 h4 NaCl precipitation; lane 5, 
hnmunoprecipitation with type IV collagen antibodies; lane 6, 
immunoprecipitation with fibronectin antiserum. Each 
sample was reduced prior to electrophoresis. The graphs at 
the top represent densitometric scans of ammonium sulfate 
precipitated medium before (a) or after (b) collagenase 
digestion. Molecular weight markers for collageneous (left- 
hand side) and noncollageneous polypeptides (right-hand 
side) are indicated by arrows. 
matrix structures such as are formed around normal 
adherent cells in culture [ 181. 
Immunohistological data have indicated that 
type III collagen and procollagen are major 
constituents of the loose connective tissue and mainly 
found in the reticular network [26]. In immuno- 
fluorescence of mouse skeletal muscle both type III 
procollagen (fig3a), flbronectin (fig3b) and type IV 
collagen (fig.3c) but no type I procollagen (fIg.3d) 
were seen in the endomysium. Similar data have been 
reported on bovine muscle [27]. The biosynthetic 
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Fig3. Indirect immunofluorescence micrographs of sectioned mouse muscle obtained with antibodies to:(a) type III procollagen; 
(b) fibronectin; (c) type IV collagen; (d) type I procollagen. The endomysium stains positive ina-c; fii.3b includes a section 
through a peripheral nerve. The gaps between the muscle fibers are artifacts due to dehydration n the fiation process. X 220. 
data presented here suggests hat the muscle cells 
themselves may produce components of the 
endomysium. 
The rhabdomyo~rcoma cell line appears to be a 
good source for isolating intact type III procollagen 
in amounts ufficient for chemical studies. Previous 
attempts to study post-translational modifications of 
type III procollagen, i.e., formation of interchain 
disulfide bonds [23] and of feedback inhibition by 
procollagen peptides [5,6] were hampered by the 
high level of type I procollagen production in the cul- 
tures used. Here again, this cell line may be helpful 
for circumventing these problems. 
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